Bencianol causes a dose-related (1-100 μg/mL) reversal of contractions induced by nor-adrenaline, 5-hydroxytryptamine, angiotensin II, prostaglandin F2a, and U-46619 (a thromboxane-A2 mimetic). Bencianol is more effective against contractions induced by EC50 compared to maximal concentrations of each agent and is least effective against the thromboxane-A2 mimetic, U-46619 [1]. Bencianol (0.1-100 nM) produces cytoprotective effects against CCl4 induced cell injury [2].